The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease

Rho-associated kinases ROCK1 and ROCK2 are serine/threonine kinases that are downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in diverse cellular activities including actin cytoskeleton organization, cell adhesion and motility, proliferation and apoptosis, remodeling...

Full description

Bibliographic Details
Main Authors: Svenja eHartmann, Anne J. Ridley, Susanne eLutz
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00276/full
_version_ 1817969061936496640
author Svenja eHartmann
Svenja eHartmann
Anne J. Ridley
Susanne eLutz
author_facet Svenja eHartmann
Svenja eHartmann
Anne J. Ridley
Susanne eLutz
author_sort Svenja eHartmann
collection DOAJ
description Rho-associated kinases ROCK1 and ROCK2 are serine/threonine kinases that are downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in diverse cellular activities including actin cytoskeleton organization, cell adhesion and motility, proliferation and apoptosis, remodeling of the extracellular matrix and smooth muscle cell contraction. The role of ROCK1 and ROCK2 has long been considered to be similar; however, it is now clear that they do not always have the same functions. Moreover, depending on their subcellular localization, activation, and other environmental factors, ROCK signaling can have different effects on cellular function. With respect to the heart, findings in isoform-specific knockout mice argue for a role of ROCK1 and ROCK2 in the pathogenesis of cardiac fibrosis and cardiac hypertrophy, respectively. Increased ROCK activity could play a pivotal role in processes leading to cardiovascular diseases such as hypertension, pulmonary hypertension, angina pectoris, vasospastic angina, heart failure, and stroke, and thus ROCK activity is a potential new biomarker for heart disease. Pharmacological ROCK inhibition reduces the enhanced ROCK activity in patients, accompanied with a measurable improvement in medical condition. In this review, we focus on recent findings regarding ROCK signaling in the pathogenesis of cardiovascular disease, with a special focus on differences between ROCK1 and ROCK2 function.
first_indexed 2024-04-13T20:16:38Z
format Article
id doaj.art-afcfad26f67c4cbcb4f5264eff5dd52f
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T20:16:38Z
publishDate 2015-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-afcfad26f67c4cbcb4f5264eff5dd52f2022-12-22T02:31:42ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122015-11-01610.3389/fphar.2015.00276158579The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular diseaseSvenja eHartmann0Svenja eHartmann1Anne J. Ridley2Susanne eLutz3University Medical Center, GoettingenKing's College LondonKing's College LondonUniversity Medical Center, GoettingenRho-associated kinases ROCK1 and ROCK2 are serine/threonine kinases that are downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in diverse cellular activities including actin cytoskeleton organization, cell adhesion and motility, proliferation and apoptosis, remodeling of the extracellular matrix and smooth muscle cell contraction. The role of ROCK1 and ROCK2 has long been considered to be similar; however, it is now clear that they do not always have the same functions. Moreover, depending on their subcellular localization, activation, and other environmental factors, ROCK signaling can have different effects on cellular function. With respect to the heart, findings in isoform-specific knockout mice argue for a role of ROCK1 and ROCK2 in the pathogenesis of cardiac fibrosis and cardiac hypertrophy, respectively. Increased ROCK activity could play a pivotal role in processes leading to cardiovascular diseases such as hypertension, pulmonary hypertension, angina pectoris, vasospastic angina, heart failure, and stroke, and thus ROCK activity is a potential new biomarker for heart disease. Pharmacological ROCK inhibition reduces the enhanced ROCK activity in patients, accompanied with a measurable improvement in medical condition. In this review, we focus on recent findings regarding ROCK signaling in the pathogenesis of cardiovascular disease, with a special focus on differences between ROCK1 and ROCK2 function.http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00276/fullFibrosisHeartHypertrophycardiovascular diseaserho-kinaseinhibitor
spellingShingle Svenja eHartmann
Svenja eHartmann
Anne J. Ridley
Susanne eLutz
The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
Frontiers in Pharmacology
Fibrosis
Heart
Hypertrophy
cardiovascular disease
rho-kinase
inhibitor
title The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
title_full The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
title_fullStr The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
title_full_unstemmed The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
title_short The function of Rho-dependent kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
title_sort function of rho dependent kinases rock1 and rock2 in the pathogenesis of cardiovascular disease
topic Fibrosis
Heart
Hypertrophy
cardiovascular disease
rho-kinase
inhibitor
url http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00276/full
work_keys_str_mv AT svenjaehartmann thefunctionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT svenjaehartmann thefunctionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT annejridley thefunctionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT susanneelutz thefunctionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT svenjaehartmann functionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT svenjaehartmann functionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT annejridley functionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease
AT susanneelutz functionofrhodependentkinasesrock1androck2inthepathogenesisofcardiovasculardisease